Hiroyoshi Takemoto

849 citations
35 papers · 577 indexed · h-index 11
Topics
Colorectal Cancer Treatments and Studies (10 papers)Gastric Cancer Management and Outcomes (7 papers)Hepatocellular Carcinoma Treatment and Prognosis (4 papers)

In The Last Decade

Hiroyoshi Takemoto

31 papers receiving 567 citations

Peers

Hiroyoshi Takemoto
Comparison fields: 5 of 80
  • Oncology 256
  • Molecular Biology 235
  • Surgery 152
  • Pulmonary and Respiratory Medicine 80
  • Biophysics 63
Replace Asier Antoranz with:
Asier Antoranz Belgium
Jönsson Pe Sweden
Simon Jacob Canada
Hao Ding China
Shi Chang China
Kunwu Yu China
Anand Rajan United States
Mário Mourão Netto Brazil
Marco Calvaruso Italy
Alexander Nguyen United States
Hiroyoshi Takemoto relative to Asier Antoranz Belgium Asier Antoranz's profile →
Citations per field
00.5×10×20×30×35×
Asier Antoranz · 1×
Citations per year

Countries citing papers authored by Hiroyoshi Takemoto

Since Specialization
Citations

This map shows the geographic impact of Hiroyoshi Takemoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyoshi Takemoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyoshi Takemoto more than expected).

Fields of papers citing papers by Hiroyoshi Takemoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyoshi Takemoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyoshi Takemoto. The network helps show where Hiroyoshi Takemoto may publish in the future.

Co-authorship network of co-authors of Hiroyoshi Takemoto

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyoshi Takemoto. A scholar is included among the top collaborators of Hiroyoshi Takemoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyoshi Takemoto. Hiroyoshi Takemoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3
KRAS野生型転移性結腸直腸癌(太平洋研究)患者におけるフルオロピリミジンの有無による第2線パニツムマブおよびイリノテカンの多施設オープンラベル無作為化第II相試験【JST・京大機械翻訳】
1
4 1
5 3
6 5
7 2
8 99
9 4
10 2
11 14
12 49
13
[A case of SPT therapy( S-1+CDDP+trastuzumab) was successful for HER2-positive gastric cancer accompanied by distant lymph node metastasis].
0
14 27
15 4
16 5
17 71
18 61
19 17
20
[A case of IGF-II producing rectal cancer with recurrent hypoglycemia].
1

About Hiroyoshi Takemoto

Hiroyoshi Takemoto is a scholar working on Microbiology, Oncology and Hepatology, having authored 35 papers that have together received 577 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (10 papers), Gastric Cancer Management and Outcomes (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). The work is most often cited by research in Biophysics (63 citations), Oncology (256 citations) and Structural Biology (6 citations). Hiroyoshi Takemoto has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include Yuichiro� Doki, Hitoshi Shiozaki, Morito Monden, Yoshiyuki Fujiwara, Masahiko Yano, Takushi Yasuda, Hideyuki Mishima, Naoki Nagata, Yujiro Nakahara and Hiroshi Miyata. Their work appears in journals such as Journal of Clinical Oncology, Scientific Reports and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026